TBX1 and chordoma: Immunocytochemical analysis of CuB-treated (20 μM, 48 h) chordoma cell lines U-CH1, MUG-Chor1, and UM-Chor1 confirmed a dramatic reduction in brachyury levels (Figure 3a).